Patent ID: 7423036

Claim:
A compound of formula 1, wherein n is 1, 2, 3 or 4; A is a double-bonded group selected from among —O, —CR 4 R 5 , —NR 6 , —S, —CR 4 R 5 —O, —CR 4 R 5 —NR 6 , —CH═CH or —CH 2 —CH 2 —; R 1 is —C 1-6 -alkyl; R 2 and R 3 , which may be identical or different, are H, C 1-6 -alkyl, C 2-6 -alkenyl, C 2-6 -alkynyl, C 3-6 -cycloalkyl, C 1-6 -haloalkyl, —O—C 1-6 -haloalkyl, halogen, OH, CN, NO 2 , O—C 1-6 -alkyl, —C 2-6 -alkyl-OH, NH 2 , NH—C 1-6 -alkyl, N(C 1-6 -alkyl) 2 , NHCO—C 1-6 -alkyl, NHSO 2 —C 1-6 -alkyl, S—C 1-6 -alkyl, SO—C 1-6 -alkyl, SO 2 —C 1-6 -alkyl, SO 2 NH 2 , SO 2 NH—C 1-6 -alkyl, SO 2 N(C 1-6 -alkyl) 2 , CONH 2 , CONH—C 1-6 -alkyl, CON(C 1-6 -alkyl) 2 , —CO—C 1-6 -alkyl, COOH or COO—C 1-4 -alkyl, or R 2 and R 3 together are a double-bonded group selected from —O—CR 4 R 5 —O, —O—CR 4 R 5 —NR 6 or —CH═CH—CH═CH—; R 4 is H or C 1-6 -alkyl; R 5 is H or C 1-6 -alkyl; R 6 is H or C 1-6 -alkyl, optionally in the form of an individual enantiomer thereof, a mixture of the individual enantiomers or a racemate, optionally in the form of a pharmacologically acceptable acid addition salt thereof, as well as optionally in the form of a hydrate thereof.